You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

List of Excipients in API guanfacine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing guanfacine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Takeda Pharmaceuticals America Inc INTUNIV guanfacine 54092-513 CELLULOSE, MICROCRYSTALLINE
Takeda Pharmaceuticals America Inc INTUNIV guanfacine 54092-513 CROSPOVIDONE
Takeda Pharmaceuticals America Inc INTUNIV guanfacine 54092-513 FUMARIC ACID
Takeda Pharmaceuticals America Inc INTUNIV guanfacine 54092-513 GLYCERYL DIBEHENATE
Takeda Pharmaceuticals America Inc INTUNIV guanfacine 54092-513 HYPROMELLOSE 2208
Takeda Pharmaceuticals America Inc INTUNIV guanfacine 54092-513 LACTOSE MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing guanfacine

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc guanfacine 0093-5960 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc guanfacine 0093-5960 CROSPOVIDONE
Teva Pharmaceuticals USA Inc guanfacine 0093-5960 FUMARIC ACID
Teva Pharmaceuticals USA Inc guanfacine 0093-5960 GLYCERYL DIBEHENATE
Teva Pharmaceuticals USA Inc guanfacine 0093-5960 LACTOSE MONOHYDRATE
Teva Pharmaceuticals USA Inc guanfacine 0093-5960 METHACRYLIC ACID
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for guanfacine

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77492

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1--ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FD&C YELLOW NO. 6 ALUMINUM LAKE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FUMARIC ACID

Excipient focus: GLYCERYL BEHENATE/EICOSADIOATE

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHACRYLIC ACID

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ACETATE

Excipient focus: POLYVINYL ACETATE PHTHALATE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K12

Excipient focus: POVIDONE K29/32

Excipient focus: POVIDONE K90

Excipient focus: POVIDONES

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: TALC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links